Agenda

September 12, 2025
Breakfast and Non-CME/CE Bonus Presentation
CRYSVITA® (burosumab-twza): Targeted Treatment for Adults with X-Linked Hypophosphatemia (XLH)
7:00 am
 — 
8:00 am
Session Moderator
Presentations In This Session